Perpetua Medical AB (publ) OMXSTO:PERP_B:
Q4 NET SALES AMOUNTED TO SEK 5,157 (4,164) THOUSAND
Q4 OPERATING PROFIT AMOUNTED TO SEK -3,922 THOUSAND (-1,105)
Perpetua Medical Q4 Oper Loss Widens To SEK 3.9 Mln
Earlier from Perpetua Medical Ab Class B
- Perpetua Medical Approves Directed New Issue Of Up To 2,355,713 Shares
- Perpetua Medical Q3 Net Sales At SEK 3.48 Mln
- Perpetua Medical's Subsidiary Gets Significant Order
- PERP_B: Q2 2025 sales up 165%, losses reduced, major acquisition and asset sale boost outlook